1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Xu, X. Eletsky, A. Mills, J.L. Pulavarti, S.V.S.R.K. Lee, D. Kohan, E. Janjua, H. Xiao, R. Acton, T.B. Everett, J.K. Montelione, G.T. Szyperski, T. Northeast Structural Genomics Consortium (NESG) http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking To be Published 0353 Solution NMR Structure of Homeobox 2 Domain from Human ZHX1 repressor, Northeast Structural Genomics Consortium (NESG) Target HR7907F 10.2210/pdb2ly9/pdb pdb_00002ly9 8710.016 Zinc fingers and homeoboxes protein 1 DNA binding Homeobox 2 residues 462-532 1 man polymer no no SHMPDSFGIRAKKTKEQLAELKVSYLKNQFPHDSEIIRLMKITGLTKGEIKKWFSDTRYNQRNSKSNQCLHLNN SHMPDSFGIRAKKTKEQLAELKVSYLKNQFPHDSEIIRLMKITGLTKGEIKKWFSDTRYNQRNSKSNQCLHLNN A NESG-HR7907F polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human sample ZHX1 9606 Homo sapiens 469008 Escherichia coli BL21(DE3)pMgK pET15Avi6HT_NESG Northeast Structural Genomics Consortium NESG PSI:Biology database_2 pdbx_database_status pdbx_nmr_software struct_ref_seq_dif repository Initial release Data collection Database references Other 1 0 2012-11-14 1 1 2023-06-14 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.status_code_nmr_data _pdbx_nmr_software.name _struct_ref_seq_dif.details Y BMRB Y RCSB 2012-09-14 REL REL REL REL 875 278 176 217 204 0 0 36 36 target function 100 20 2D 1H-15N HSQC 2D 1H-13C HSQC 3D HNCO (4,3)D GFT CABCA(CO)NHN (4,3)D GFT HNNCABCA 2D 1H-13C HSQC (4,3)D GFT HCCH-COSY alipahtic 3D (H)CCH-TOCSY aliphatic 3D 13C/15N-edited NOESY (4,3)D GFT HABCAB(CO)NH 3D (H)CCH-COSY aromatic 0.4 mM [U-100% 13C; U-100% 15N] 0.02 % 10 mM 5 mM 100 mM 1 % 20 mM 50 uM 0.3 mM [5% 13C; U-100% 15N] 0.02 % 10 mM 5 mM 100 mM 1 % 20 mM 50 uM 6.5 1 atm 298 K STRUCTURE DETERMINATION WAS PERFORMED BY RUNNING CYANA AND ASDP IN PARALLEL USING NOE-BASED CONSTRAINTS AND PHI AND PSI DIHEDRAL ANGLE CONSTRAINTS FROM TALOS+. CONSENSUS PEAK ASSIGNMENTS WERE SELECTED AND USED IN ITERATIVE REFINEMENT WITH CYANA. THE 20 CONFORMERS OUT OF 100 WITH THE LOWEST TARGET FUNCTION WERE FURTHER REFINED BY SIMULATED ANNEALING IN EXPLICIT WATER BATH USING THE PROGRAM CNS WITH PARAM19 FORCE FIELD NMR ENSEMBLE INFORMATION simulated annealing 1 lowest energy 0.4 mM [U-100% 13C; U-100% 15N] HR7907F, 0.02 % sodium azide, 10 mM DTT, 5 mM calcium chloride, 100 mM sodium chloride, 1 x Proteinase Inhibitors, 20 mM MES, 50 uM DSS, 90% H2O/10% D2O 90% H2O/10% D2O 0.3 mM [5% 13C; U-100% 15N] HR7907F, 0.02 % sodium azide, 10 mM DTT, 5 mM calcium chloride, 100 mM sodium chloride, 1 x Proteinase Inhibitors, 20 mM MES, 50 uM DSS, 90% H2O/10% D2O 90% H2O/10% D2O Keller and Wuthrich peak picking CARA 1.8.4 Keller and Wuthrich chemical shift assignment CARA 1.8.4 Guntert, Mumenthaler and Wuthrich refinement CYANA 3.0 Guntert, Mumenthaler and Wuthrich geometry optimization CYANA 3.0 Guntert, Mumenthaler and Wuthrich structure solution CYANA 3.0 Huang, Tejero, Powers and Montelione data analysis AS-DP 1.0 Huang, Tejero, Powers and Montelione refinement AS-DP 1.0 Zimmerman, Moseley, Kulikowski and Montelione data analysis AutoAssign 2.3.0 Zimmerman, Moseley, Kulikowski and Montelione chemical shift assignment AutoAssign 2.3.0 Bartels et al. data analysis XEASY Varian collection VnmrJ Shen, Cornilescu, Delaglio and Bax geometry optimization TALOS+ Bhattacharya, Montelione structure validation PSVS 600 Varian INOVA Varian INOVA 750 Varian INOVA Varian INOVA SER 1 n 1 SER 1 A HIS 2 n 2 HIS 2 A MET 3 n 3 MET 3 A PRO 4 n 4 PRO 4 A ASP 5 n 5 ASP 5 A SER 6 n 6 SER 6 A PHE 7 n 7 PHE 7 A GLY 8 n 8 GLY 8 A ILE 9 n 9 ILE 9 A ARG 10 n 10 ARG 10 A ALA 11 n 11 ALA 11 A LYS 12 n 12 LYS 12 A LYS 13 n 13 LYS 13 A THR 14 n 14 THR 14 A LYS 15 n 15 LYS 15 A GLU 16 n 16 GLU 16 A GLN 17 n 17 GLN 17 A LEU 18 n 18 LEU 18 A ALA 19 n 19 ALA 19 A GLU 20 n 20 GLU 20 A LEU 21 n 21 LEU 21 A LYS 22 n 22 LYS 22 A VAL 23 n 23 VAL 23 A SER 24 n 24 SER 24 A TYR 25 n 25 TYR 25 A LEU 26 n 26 LEU 26 A LYS 27 n 27 LYS 27 A ASN 28 n 28 ASN 28 A GLN 29 n 29 GLN 29 A PHE 30 n 30 PHE 30 A PRO 31 n 31 PRO 31 A HIS 32 n 32 HIS 32 A ASP 33 n 33 ASP 33 A SER 34 n 34 SER 34 A GLU 35 n 35 GLU 35 A ILE 36 n 36 ILE 36 A ILE 37 n 37 ILE 37 A ARG 38 n 38 ARG 38 A LEU 39 n 39 LEU 39 A MET 40 n 40 MET 40 A LYS 41 n 41 LYS 41 A ILE 42 n 42 ILE 42 A THR 43 n 43 THR 43 A GLY 44 n 44 GLY 44 A LEU 45 n 45 LEU 45 A THR 46 n 46 THR 46 A LYS 47 n 47 LYS 47 A GLY 48 n 48 GLY 48 A GLU 49 n 49 GLU 49 A ILE 50 n 50 ILE 50 A LYS 51 n 51 LYS 51 A LYS 52 n 52 LYS 52 A TRP 53 n 53 TRP 53 A PHE 54 n 54 PHE 54 A SER 55 n 55 SER 55 A ASP 56 n 56 ASP 56 A THR 57 n 57 THR 57 A ARG 58 n 58 ARG 58 A TYR 59 n 59 TYR 59 A ASN 60 n 60 ASN 60 A GLN 61 n 61 GLN 61 A ARG 62 n 62 ARG 62 A ASN 63 n 63 ASN 63 A SER 64 n 64 SER 64 A LYS 65 n 65 LYS 65 A SER 66 n 66 SER 66 A ASN 67 n 67 ASN 67 A GLN 68 n 68 GLN 68 A CYS 69 n 69 CYS 69 A LEU 70 n 70 LEU 70 A HIS 71 n 71 HIS 71 A LEU 72 n 72 LEU 72 A ASN 73 n 73 ASN 73 A ASN 74 n 74 ASN 74 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A HIS 2 -130.79 -46.19 1 A SER 6 -150.74 12.13 1 A ARG 10 59.34 19.29 1 A SER 66 72.89 -60.53 1 A ASN 67 -84.31 -70.56 2 A MET 3 64.68 103.40 2 A ASP 5 -67.34 87.23 2 A ALA 11 58.16 -159.57 2 A LYS 13 -69.45 99.41 2 A CYS 69 66.63 -175.73 2 A LEU 70 75.39 -70.41 3 A ASP 5 71.75 134.10 3 A ALA 11 72.62 -73.22 3 A THR 43 -90.65 -61.62 3 A SER 66 65.05 172.62 3 A ASN 73 -66.43 97.61 4 A PRO 4 -53.39 105.91 4 A ILE 9 -63.49 99.56 4 A ARG 10 61.54 -72.72 4 A ALA 11 -67.97 92.38 4 A ASN 63 -107.08 45.66 5 A MET 3 71.46 151.28 5 A PRO 4 -56.02 92.59 5 A PHE 7 -62.20 95.35 5 A ASN 67 55.79 -154.28 5 A LEU 70 -154.80 -66.92 6 A HIS 2 -158.53 16.06 6 A MET 3 -153.23 86.63 6 A SER 6 -117.41 -79.89 6 A HIS 32 -62.68 -79.35 6 A ASP 33 -179.73 -52.15 6 A CYS 69 67.38 86.85 7 A ASP 5 -84.89 32.19 7 A PHE 7 62.41 90.06 7 A ARG 10 -156.09 -41.76 7 A LYS 13 66.66 177.25 7 A HIS 32 -68.73 -70.95 7 A ASP 33 -159.32 -43.23 8 A PHE 7 -121.61 -53.18 8 A ARG 10 64.17 89.75 8 A ASN 28 -164.85 100.44 8 A HIS 32 -79.99 -71.32 8 A ASP 33 -155.40 -54.95 8 A GLN 61 -91.93 -60.69 8 A LYS 65 -86.85 -82.47 8 A SER 66 -178.32 -67.06 8 A ASN 67 59.05 103.44 8 A LEU 70 -83.20 43.33 9 A ASP 5 -148.49 -76.45 9 A SER 6 68.52 -65.41 9 A PHE 7 66.85 -78.97 9 A LYS 12 -160.77 -42.59 9 A ASN 28 -171.83 142.12 9 A GLN 68 -73.35 -157.87 9 A CYS 69 -69.74 82.02 10 A PHE 7 -65.74 87.78 10 A ALA 11 59.79 -159.85 10 A LYS 13 57.92 -171.77 10 A SER 64 -69.60 92.26 10 A ASN 67 60.47 76.93 11 A ARG 10 -138.62 -55.19 11 A ALA 11 -150.96 41.33 11 A ASN 67 57.13 79.46 12 A PHE 7 -100.02 -166.69 12 A SER 66 -164.61 100.65 12 A ASN 67 64.89 136.06 12 A GLN 68 -159.26 -56.69 12 A LEU 72 54.00 77.05 13 A SER 6 68.34 156.13 13 A ILE 9 -66.67 98.70 13 A ASN 28 -160.34 103.43 13 A HIS 32 -89.67 -91.52 13 A ASP 33 -147.32 -57.22 13 A SER 64 -164.54 -47.13 13 A LYS 65 64.03 -178.06 13 A CYS 69 -67.84 97.97 14 A MET 3 -57.07 105.01 14 A LYS 13 -57.02 105.62 14 A HIS 32 -87.02 -75.89 14 A ASP 33 -150.95 -58.37 14 A LYS 65 68.68 110.05 15 A MET 3 66.77 89.40 15 A ALA 11 64.07 100.32 15 A ILE 42 -92.37 -64.61 15 A ASN 63 -68.59 86.87 15 A ASN 67 -69.32 96.20 15 A LEU 70 60.72 90.56 15 A HIS 71 69.08 113.43 16 A ASP 5 -74.08 -78.88 16 A SER 6 53.46 71.88 16 A ARG 62 -147.99 27.89 16 A ASN 63 -58.96 106.62 16 A ASN 67 63.19 -178.40 16 A CYS 69 60.97 93.53 17 A MET 3 67.30 162.39 17 A PRO 4 -74.04 39.70 17 A SER 6 -178.88 112.96 17 A ARG 10 -135.33 -70.09 17 A ASN 67 68.32 171.65 17 A HIS 71 69.56 119.92 18 A PHE 7 -63.44 96.40 18 A ALA 11 -152.43 27.82 18 A LYS 13 67.58 114.79 18 A CYS 69 -90.61 -91.24 19 A PRO 4 -89.01 41.80 19 A ASN 28 -174.56 142.19 19 A PHE 30 -114.69 79.91 19 A HIS 32 -73.74 -77.34 19 A ASP 33 -158.25 -58.16 19 A ARG 62 -156.41 -16.88 19 A SER 64 -55.55 96.28 19 A SER 66 71.14 64.67 19 A CYS 69 62.14 72.92 19 A HIS 71 -49.59 101.99 20 A HIS 2 64.67 99.46 20 A MET 3 70.05 153.62 20 A ARG 62 -161.59 -55.09 20 A ASN 63 61.50 -175.84 20 A SER 64 -142.93 -53.90 20 A LYS 65 -165.17 -40.32 20 A GLN 68 54.87 84.53 20 A ASN 73 -58.21 90.93 lowest energy, model 1 Solution NMR Structure of Homeobox 2 Domain from Human ZHX1 repressor, Northeast Structural Genomics Consortium (NESG) Target HR7907F 1 N N A THR 14 A THR 14 HELX_P A ASN 28 A ASN 28 1 1 15 A HIS 32 A HIS 32 HELX_P A GLY 44 A GLY 44 1 2 13 A THR 46 A THR 46 HELX_P A GLN 61 A GLN 61 1 3 16 TRANSCRIPTION Structural Genomics, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG), PSI-Biology, Protein Structure Initiative, TRANSCRIPTION ZHX1_HUMAN UNP 1 462 Q9UKY1 PDSFGIRAKKTKEQLAELKVSYLKNQFPHDSEIIRLMKITGLTKGEIKKWFSDTRYNQRNSKSNQCLHLNN 462 532 2LY9 4 74 Q9UKY1 A 1 4 74 1 expression tag SER 1 2LY9 A Q9UKY1 UNP 1 1 expression tag HIS 2 2LY9 A Q9UKY1 UNP 2 1 expression tag MET 3 2LY9 A Q9UKY1 UNP 3